Featured Issue Briefs
The Battle on the Home Front: Jonathan Gadsden's Story
Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More
Facilitating Medical Device Innovation: De Novo Reform
The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More
Food Products Recalled by FDA
Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More
More Issue Briefs
| Date | Issue Briefs | Topic |
|---|---|---|
| Jan 2, 2012 |
Patient Story: Jamel Sawyer: A Young Man Fights MRSAOne of the most notorious multidrug-resistant superbugs, MRSA is responsible for an estimated 19,000 deaths and 360,000 hospitalizations each year in this country. Jamel’s story illustrates the twin dangers presented by emerging multidrug-resistant bacterial infections and the waning effectiveness and availability of drugs to treat them. More info |
Antibiotic Innovation |
| Sep 20, 2011 |
National Headlines Reporting on the Need for New, Lifesaving AntibioticsNational and international headlines warn that multidrug-resistant superbugs are on the rise and the pipeline of new antibiotics is running dry. More info |
Antibiotic Innovation |
| Sep 20, 2011 |
What Leading Experts are Saying about Emerging Drug-Resistant Infections and the Need for New Drugs to Treat ThemLegislators, regulators, scientists and academics agree: we are running out of antibiotics to treat drug-resistant infections—and we need new ones now. Here is what leading voices are saying about how economic, scientific and regulatory factors are impeding the development of new antibiotics, and what we can do about it. More info |
Antibiotic Innovation |
| Sep 20, 2011 |
Bill Summary: The Generating Antibiotic Incentives Now Act (H.R. 2182)The Generating Antibiotic Incentives Now (GAIN) Act of 2011 (H.R. 2182) seeks to create incentives to encourage the development of products to treat, prevent, detect and diagnose antibiotic-resistant infections. It extends the length of time an approved drug is free from competition and clarifies the regulatory pathway for new antibiotics. More info |
Antibiotic Innovation |
| Apr 12, 2012 |
Reviving the Pipeline of Life-Saving AntibioticsAntibiotic-resistant infections are a growing public health threat. At the same time, antibiotic innovation is waning. Pew, the IIDSA and PhRMA hosted a one-day conference, Reviving the Pipeline of Life-Saving Antibiotics: Exploring Solutions to Spur Innovation on September 22, 2011, exploring ways to overcome the challenges that hinder the development of new antibiotics. More info |
Drug Safety, Antibiotic Innovation |
| Mar 8, 2012 |
Testimony before the House Committee on Energy and Commerce, Subcommittee on HealthAllan Coukell, Director of Medical Programs, and Sharon Ladin, Director of the Antibiotics and Innovation Project, testify before the House Committee on Energy and Commerce, Subcommittee on Health on stimulating the development of new antibiotics urgently needed to fight serious and life-threatening bacterial infections. More info |
Drug Safety, Antibiotic Innovation |
| Apr 3, 2012 |
MRSA: A Deadly Pathogen with Fewer and Fewer Treatment OptionsStaphylococcus aureus, or staph, is a common bacterium that exists in our environment and our bodies. Most of the time it does no harm. Sometimes, however, it can cause infection and require treatment. MRSA refers to strains of S. aureus that are resistant to the antibiotic methicillin and a host of other drugs used to treat infection. More info |
Food Safety, Antibiotic Innovation |
| Apr 10, 2013 |
Antibiotics and Industrial Farming 101Each year, tens of thousands of Americans die and hundreds of thousands are hospitalized because of bacterial infections resistant to antibiotics. Antibiotic overuse on industrial farms is a big part of the problem. The largest U.S. meat and poultry producers feed antibiotics to healthy animals over much of their lives to make them grow faster and to compensate for the overcrowded and unsanitary conditions in which they are bred and slaughtered. More info |
Antibiotics in Food Animal Production |
| Apr 8, 2013 |
Multiple Organizations - Including Pew - Support DATA ActOn behalf of the undersigned organizations representing medical, public health, scientific, agricultural, environmental, animal protection, and other organizations, we urge you to include H.R. 820, the Delivering Antimicrobial Transparency in Animals (DATA) Act, as part of the final Animal Drug User Fee Act (ADUFA). This legislation provides a reasonable, common-sense approach to better understanding antibiotic use in agriculture. More info |
Antibiotics in Food Animal Production |
| Feb 26, 2013 |
Health, Science Leaders Call on Congress for More Antibiotics DataA broad coalition of medical, public health, scientific, agricultural, consumer, environmental and humane organizations, representing more than 11 million supporters, wrote a letter urging Congress to reauthorize the Animal Drug User Fee Act (ADUFA) and include in it provisions to help preserve the efficacy of antibiotics vital to protecting public health. More info |
Antibiotics in Food Animal Production |
| Nov 21, 2012 |
Pew Comments on Advance Notice of Proposed Rulemaking ''Antimicrobial Animal Drug Sales and Distribution Reporting''The Pew Campaign on Human Health and Industrial Farming submitted a letter to the U.S. Food and Drug Administration, urging the FDA to strengthen regulations pertaining to record-keeping and public reporting of antibiotic use in food animal production. More info |
Antibiotics in Food Animal Production |
| Nov 19, 2012 |
Public Health and Consumer Groups Call for Participation in Antibiotic Use MeetingsOn Nov. 2, 15 public health and consumer organizations sent a joint letter to the FDA requesting to join in discussions to consider how the misuse and overuse of antibiotics in livestock and poultry are significant contributing factors to antibiotic resistance in humans. More info |
Antibiotics in Food Animal Production |
| Aug 31, 2012 |
Save Antibiotics August Newsletter (2012)What's in your Lunchbox? & Senators Call for FDA ActionAIP Generating ActBelow is your August 2012 newsletter from the Pew Campaign on Human Health and Industrial Farming. This edition features a video of Supermoms visiting Capitol Hill, a new report on More info |
Antibiotics in Food Animal Production |
| Aug 28, 2012 |
Members of Congress Write Letter to FDA About Antibiotics in Food Animal ProductionTwelve United States congressmen have penned a letter to the Food and Drug Administration making recommendations on improvements to the FDA's policies on food animal production and the use of antibiotics in industrial farming. More info |
Antibiotics in Food Animal Production |
| Aug 13, 2012 |
U.S. Senators' Letter to FDA Commissioner Margaret HamburgThirteen U.S. Senators, including Sen. Dianne Feinstein and Sen. Susan Collins signed a letter to U.S. Food and Drug Administration Commissioner Margaret Hamburg calling for improvements to Guidance for Industry 209 -- which proposes voluntary reductions in the use of antibiotics in food animal production. More info |
Antibiotics in Food Animal Production |
